Our vision is a world where every person, everywhere benefits from timely access to safe, effective, and quality-assured medicines and other health products, including innovative products and emerging technologies, to attain the highest possible level of health and well-being.
Our mission is to facilitate access to safe, effective and quality-assured medicines and health products to achieve universal health coverage goals through the provision of evidence-based normative guidance, standards, specifications, policy and technical assistance to Member States. The scope of our work covers assistive technology; biologicals and biological products (including cell and gene therapies); blood products; internationally-controlled medicines and substances; medical devices, including in vitro diagnostics; medicines; and organs, tissues and cell transplantation.
Contact information
Featured
News
All →Expert Committees
Advisory groups
Databases
Publications
All →Journal articles
Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections
Meeting reports
Nigeria: Essential Medicines list 2024 (English)
United Republic of Tanzania: National Essential Medicines List (NEMLIT) 2026 (English)
Executive Summary of the WHO Implementation Workshop in the Western Pacific region: Revised WHO Guidelines on Evaluation of Biosimilars
Accelerating access to assistive technology: African Regional workshop report
Bahamas: National Essential Medicines List 2025 (English)
INN Proposed List 135
Trainings
Multimedia